-
Establishment Labs Holdings (ESTA) Announces Leadership Adjustments
-
Establishment Labs reports preliminary Q4 revenue of $64-65 million
-
Establishment Labs Inc. (ESTA) PT Raised to $86 at BTIG
-
Mizuho on Establishment Labs Inc. (ESTA): 'Clearing Air on 60k Motiva Implants: Reads Bullish for 4Q & 2026 by Our Math'
-
Establishment Labs submits Motiva implants to FDA for reconstruction use
-
Establishment Labs Inc. (ESTA) PT Raised to $84 at Needham
-
Establishment Labs Inc. (ESTA) PT Raised to $81 at BTIG
-
Establishment Labs Inc. (ESTA) PT Raised to $85 at Mizuho, Remains a Top Pick
-
Establishment Labs Inc. (ESTA) PT Raised to $70 at Needham
-
Establishment Labs Inc. (ESTA) PT Raised to $70 at BTIG
-
Establishment Labs Holdings (ESTA) Tops Q3 EPS by 13c
-
TD Cowen on Establishment Labs Inc. (ESTA): 'Minimally Invasive Portfolio Should Hit the US Ground Running in 2026'
-
Canaccord Genuity Reiterates Buy Rating on Establishment Labs Inc. (ESTA)
-
Mizuho Reiterates Outperform Rating on Establishment Labs (ESTA), 'ESTA remains a top pick'
-
Mizuho: 'ESTA remains a top pick'
-
Canaccord Genuity Starts Establishment Labs Inc. (ESTA) at Buy
-
Establishment Labs Inc. (ESTA) PT Lowered to $40 at Citi
-
Establishment Labs Holdings (ESTA) Misses Q2 EPS by 4c
-
Establishment Labs Inc. (ESTA) PT Raised to $70 at Mizuho
-
Needham Reiterates Buy Rating on Establishment Labs Inc. (ESTA)
-
Citi shuffles MedTech stocks: BDX downgraded, ITGR raised; reiterates top pick
-
BTIG Starts Establishment Labs Inc. (ESTA) at Buy
-
Needham Upgrades Establishment Labs Inc. (ESTA) to Buy
-
Needham Reiterates Hold Rating on Establishment Labs Inc. (ESTA)
-
Establishment Labs Holdings (ESTA) Tops Q1 EPS by 11c ; Offers Guidance
-
Establishment Labs Holdings (ESTA) Appoints Peter Caldini as CEO
-
Needham Starts Establishment Labs Inc. (ESTA) at Hold
-
Mizuho Reiterates Outperform Rating on Establishment Labs Inc. (ESTA)
-
TD Cowen: 'Establishment Labs Inc. (ESTA) Appears More Insulated From Tariff Headwinds'
-
TD Cowen on Medical Supplies & Devices: 'Companies Least Affected by New Reciprocal Tariffs'
-
Establishment Labs Inc. (ESTA) PT Lowered to $60 at TD Cowen; Stock Named 'Europe Best Ideas'
-
Establishment Labs Holdings (ESTA) 4800 contracts of March 40 calls trade
-
Establishment Labs Inc. (ESTA) PT Lowered to $58 at Mizuho
-
Establishment Labs Holdings (ESTA) Misses Q4 EPS by 55c
-
Establishment Labs Holdings (ESTA) Announces CEO Transition
-
Establishment Labs Holdings (ESTA) Tops Q3 EPS by 3c, Misses on Revenue; Offers FY24 Revenue Guidance
-
Establishment Labs (ESTA) Announces Three-Year Mia Femtech Clinical Results at 9th World Symposium on Ergonomic Implants
-
Mizuho Reiterates Outperform Rating on Establishment Labs Inc. (ESTA)
-
TD Cowen Reiterates Buy Rating on Establishment Labs Inc. (ESTA)
-
TD Cowen Reiterates Buy Rating on Establishment Labs Inc. (ESTA)
-
Mizuho Reiterates Outperform Rating on Establishment Labs Inc. (ESTA)
-
BTIG Reiterates Buy Rating on Establishment Labs Inc. (ESTA)
-
Establishment Labs Holdings (ESTA) Receives U.S. FDA Approval for Motiva Implants
-
Citi Opens 90-Day Upside Catalyst Watch on Establishment Labs Inc. (ESTA)
-
Establishment Labs Holdings (ESTA) Misses Q2 EPS by 11c ; Offers Guidance
-
This MedTech European stock is a new top idea for 2024 at TD Cowen

